Foghorn Therapeutics FHTX
NASDAQ FHTX
$4.91 +0.04 (+0.82%)
As of: Sep 4, 2026 · 2:33 PM EDT

Foghorn Therapeutics (FHTX) Short-term Investments (2019 - 2026)

Foghorn Therapeutics (FHTX) posted quarterly Short-term Investments of $1.2 million for Q1 2026, little changed quarter-over-quarter from $1.2 million in Q4 2025.

Analysis

Foghorn Therapeutics (FHTX) Short-term Investments (2019 - 2026) Analysis & Trends

Foghorn Therapeutics' Short-term Investments history runs 5 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • In Q1 2026, Short-term Investments changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
  • Short-term Investments for Q1 2026 stood at $1.2 million, roughly flat from $1.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $1.2 million in Q2 2025, with the low at $25000.0 in Q3 2022.
  • The 3-year median for Short-term Investments is $1.2 million (2025), against an average of $1.0 million.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Foghorn Therapeutics 346.08 Mn 278.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Sep 30, 2022 25,000.00
Sep 30, 2020 541,000.00
Dec 31, 2019 541,000.00